About CMIT

China Merchants Innovation Technology (Group) Co., Ltd
CMIT was established in December 2023 in the Shenzhen Park of Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone. Focusing on the three directions of Digital-Intelligent Technology, Life Science and Technology, and Green Technology, and through three approaches of "R&D and cultivation + industrial mergers and acquisitions + professional operations", it continuously makes due contributions to China Merchants Group in achieving high-level self-reliance and self-improvement in science and technology and building a modern industrial system. In forging the "Malik Curve" to underpin the Group's high-quality development, it aspires to stand as the vanguard and main force in China Merchants Group's "Third Venture".
Apr
Sep
Nov
Dec
China Merchants Venture Company Ltd.

China Merchants Venture Company Limited is a subsidiary and enterprise venture capital platform (CVC) of China Merchants Group, established in 2015. The company is committed to promoting the transformation and upgrading of the Group's traditional industries and the cultivation of strategic emerging industries, accelerating the investment layout of green technology, digital technology and other fields, and striving to explore and cultivate industrial investment projects.

China Merchants Research Institute of Advanced Technology

In order to accelerate the realization of high-level technological self-reliance and high-quality support for the construction of the Hong Kong International Innovation and Technology Center.It is positioned as a forward-looking and open research and development institution coordinated by the Group, with four major functions including tracking cutting-edge technology, key technology research and development.Striving to become a first-class enterprise new research and development institution with regional influence.

Tianjin Pharmaceutical Research Institute

Tianjin Institute of Pharmaceutical Research Co., Ltd. (hereinafter referred to as the Institute) was founded in 1959 and is one of the national comprehensive pharmaceutical research institutions directly under the former State Administration for Market Regulation. In 2000, it was transformed into a state-owned enterprise system in Tianjin. In 2018, it became a modern research-oriented pharmaceutical enterprise under China Merchants Group through mixed ownership reform of state-owned enterprises.